DTRMWXHS-12

N/A

Report date: 2025/01/09 20:00:05
NME

Base Information

Drug NameDTRMWXHS-12
Drug Alias NameDTRMWXHS-12DTRM-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsRichter's SyndromeLymphoma, Mantle-CellLymphoma, Follicular +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Dtrm Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Dtrm Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Mantle-Cell
Inactive IndicationsRichter's SyndromeLymphoma, FollicularLymphoma, Large B-Cell, Diffuse +[6] 

Other Information

ATC CodeN/A
Related LinksN/A